search query: @author Stipp, D. / total: 7
reference: 2 / 7
| Author: | Stipp, D. |
| Title: | Why Pfizer is so hot |
| Journal: | Fortune
1998 : MAY, VOL. 137:9, p. 52-56 |
| Index terms: | COMPANIES FINANCIAL PERFORMANCE PHARMACEUTICAL INDUSTRY GROWTH MARKETS |
| Language: | eng |
| Abstract: | With one of the richest product pipelines in the Fortune 500, Pfizer is on a roll that will continue for years to come. Pfizer may upstage Merck as the drug industry's premier player. In the past years, Pfizer has expanded its drug pipeline faster independently than its competitors have expanded theirs by merging. |
SCIMA